Forty percent of all deaths in the Tri-Cities region are related to some form of heart disease. Dr. William T. Abraham will discuss this issue and other dealings with cardiovascular health at the 24th Annual Thomas W. Green Memorial Lecture, titled “Current and Future Therapies for Congestive Heart Failure.”
The lecture will be given at noon on Tuesday in the Monarch Auditorium of the Bristol Regional Medical Center.
The public is invited to attend the discussion, which will include treatment of congestive heart failure; first signs of a heart attack; the effect of genes, diet, alcohol and weight on heart disease; and heart attacks associated with athletes, a recent cause of concern after the deaths of several high school, college and professional athletes.
“We invite the general public as well as health care professionals to come hear Abraham because heart failure represents a major and growing public health concern in the United States and other developed countries,” says Dr. Raymond Massengill Jr., founding organizer of the Green lecture series and assistant dean of the James H. Quillen College of Medicine. “In fact, heart failure is the fastest growing form of cardiovascular disease in America.”
Massengill emphasizes that this lecture is not just for those involved in cardiology. “Physicians of any field, even audiology or allied health, as well as the lay public, will profit from hearing Dr. Abraham. He is a recognized authority in this field, and his lectures have been well received by a number of diversified audiences,” she said.
Abraham is the Gill Professor of Preventive Cardiology, professor of medicine and chief of the Division of Cardiovascular Medicine, co-director of the Linda and Jack Gill Heart Institute, and director of the Section of Heart Failure and Transplantation at the University of Kentucky’s College of Medicine in Lexington.
The lecture will also focus on the improving prognosis for heart failure patients, as advanced technologies allow heart failure to be treated as a chronic disease rather than a terminal illness.

Author